Reports
Sale
Asia Pacific Protein Expression Market Size, Share, Growth: By Product: Expression Vectors, Competent Cells, Reagents, Instruments, Services; By Application: Industrial, Research, Therapeutic; By System Type: Mammalian Cell Expression System, Others; By End User: Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Asia Pacific Protein Expression Market Outlook
The global protein expression market size was valued at USD 3 billion in 2023, with Asia Pacific holding a significant market share. The market is driven by the increased protein-based research and development activities. It is expected to grow at a CAGR of 5.40% during the forecast period of 2024-2032, with the values likely to attain USD 4.9 billion by 2032.
Key Takeaways
- Recent studies suggest that 80% of the population aged 60 or above in China is affected by at least one chronic disease. The rising prevalence of such chronic conditions is expected to fuel market growth for protein expression systems.
- One of the major Asia Pacific protein expression market trends is increased investment in biologics manufacturing facilities, which is likely to stimulate technological advancement and innovation in protein expression technologies. In November 2023, an Indian CDMO Aragen Life Sciences announced the confirmation of USD 30 million for setting up a biologics manufacturing site in Bengaluru (India) to boost its bioproduction capabilities including the production of therapeutic proteins.
- In the Asia Pacific region, the rising demand for biologic drugs, including monoclonal antibodies and recombinant proteins, owing to the growing need for targeted therapeutics is expected to elevate market value in the coming years.
Asia Pacific Protein Expression Market Analysis
Protein expression can be defined as a process in which proteins are produced, modified, and regulated in living organisms. Protein expression technologies can be utilized to synthesize therapeutic proteins, antibodies, and other biologics for treating various diseases. Such technologies are also employed in the development and production of vaccines against infectious diseases. The increased application of protein expression systems to facilitate drug development, disease diagnosis, and personalized medicine, is significantly contributing to the Asia Pacific protein expression market growth.
In Asia Pacific, the burden of chronic diseases such as cancer, cardiovascular diseases, and diabetes, is increasing rapidly which can be attributed to the growing aging population, sedentary lifestyle, and environmental factors, among others. Recent studies suggest that 80% of the population aged years 60 or above in China is affected by at least one chronic disease. To manage these chronic conditions, effective treatment options in the form of monoclonal antibodies, recombinant proteins, and other biologics, are required. Protein expression systems are an essential component in the production of these therapeutic proteins. Thus, the rising prevalence of chronic diseases is expected to fuel the Asia Pacific protein expression market demand in the forecast period.
One of the major market trends is increased investment in biologics manufacturing facilities, which is likely to stimulate technological advancement and innovation in protein expression technologies. In November 2023, an India-based contract development and manufacturing organization Aragen Life Sciences announced the confirmation of USD 30 million for setting up a biologics manufacturing site in Bengaluru (India) to boost its bioproduction capabilities. The facility, spanning over 160,000 square feet, is also set to develop and produce fusion proteins as well as therapeutic proteins. Such substantial investments are poised to expand the capacity for protein expression and production, thereby augmenting the Asia Pacific protein expression market share.
The market is witnessing an increased demand for biologic drugs, including monoclonal antibodies and recombinant proteins in the Asia Pacific region, owing to the rising prevalence of chronic diseases and the need for targeted therapeutics. This directly impacts the market dynamics for protein expression technologies as they are essential to produce biologics. Further, the rising healthcare expenditures, advancements in biotechnology, and increased investment in research infrastructure are anticipated to accelerate market growth in the forecast period.
Asia Pacific Protein Expression Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product | Expression Vectors, Competent Cells, Reagents, Instruments, Services |
| Application | Industrial, Research, Therapeutic |
| System Type | Mammalian Cell Expression System, Yeast Cell Expression System, Insect Cell Expression System |
| End User | Academic Research, Contract Research Organizations, Pharmaceutical & Biotechnology Companies |
| Country | China, Japan, India, ASEAN, Australia, Others |
Asia Pacific Protein Expression Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Merck KGaA
- Thermo Fisher Scientific Inc.
- GenScript Biotech Corporation
- Agilent Technologies, Inc.
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN
- Promega Corporation
- GE Healthcare
- Bioneer Corporation
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by System Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Asia Pacific Protein Expression Market Overview
3.1 Asia Pacific Protein Expression Market Historical Value (2017-2023)
3.2 Asia Pacific Protein Expression Market Forecast Value (2024-2032)
4 Asia Pacific Protein Expression Market Landscape*
4.1 Asia Pacific Neonatal Ventilators: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Asia Pacific Neonatal Ventilators: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
5 Asia Pacific Protein Expression Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Asia Pacific Protein Expression Market Segmentation (2017-2032)
6.1 Asia Pacific Protein Expression Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Expression Vectors
6.1.3 Competent Cells
6.1.4 Reagents
6.1.5 Instruments
6.1.6 Services
6.2 Asia Pacific Protein Expression Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Industrial
6.2.3 Research
6.2.4 Therapeutic
6.3 Asia Pacific Protein Expression Market (2017-2032) by System Type
6.3.1 Market Overview
6.3.2 Mammalian Cell Expression System
6.3.3 Yeast Cell Expression System
6.3.4 Insect Cell Expression System
6.4 Asia Pacific Protein Expression Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Academic Research
6.4.3 Contract Research Organizations
6.4.4 Pharmaceutical & Biotechnology Companies
6.5 Asia Pacific Protein Expression Market (2017-2032) by Country
6.5.1 Market Overview
6.5.2 China
6.5.3 Japan
6.5.4 India
6.5.5 ASEAN
6.5.6 Australia
6.5.7 Others
7 China Protein Expression Market (2017-2032)
7.1 China Protein Expression Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Expression Vectors
7.1.3 Competent Cells
7.1.4 Reagents
7.1.5 Instruments
7.1.6 Services
7.2 China Protein Expression Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Industrial
7.2.3 Research
7.2.4 Therapeutic
7.3 China Protein Expression Market (2017-2032) by System Type
7.3.1 Market Overview
7.3.2 Mammalian Cell Expression System
7.3.3 Yeast Cell Expression System
7.3.4 Insect Cell Expression System
7.4 China Protein Expression Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Academic Research
7.4.3 Contract Research Organizations
7.4.4 Pharmaceutical & Biotechnology Companies
8 Japan Protein Expression Market (2017-2032)
8.1 Japan Protein Expression Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Expression Vectors
8.1.3 Competent Cells
8.1.4 Reagents
8.1.5 Instruments
8.1.6 Services
8.2 Japan Protein Expression Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Industrial
8.2.3 Research
8.2.4 Therapeutic
8.3 Japan Protein Expression Market (2017-2032) by System Type
8.3.1 Market Overview
8.3.2 Mammalian Cell Expression System
8.3.3 Yeast Cell Expression System
8.3.4 Insect Cell Expression System
8.4 Japan Protein Expression Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Academic Research
8.4.3 Contract Research Organizations
8.4.4 Pharmaceutical & Biotechnology Companies
9 India Protein Expression Market (2017-2032)
9.1 India Protein Expression Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Expression Vectors
9.1.3 Competent Cells
9.1.4 Reagents
9.1.5 Instruments
9.1.6 Services
9.2 India Protein Expression Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Industrial
9.2.3 Research
9.2.4 Therapeutic
9.3 India Protein Expression Market (2017-2032) by System Type
9.3.1 Market Overview
9.3.2 Mammalian Cell Expression System
9.3.3 Yeast Cell Expression System
9.3.4 Insect Cell Expression System
9.4 India Protein Expression Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Academic Research
9.4.3 Contract Research Organizations
9.4.4 Pharmaceutical & Biotechnology Companies
10 ASEAN Protein Expression Market (2017-2032)
10.1 ASEAN Protein Expression Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Expression Vectors
10.1.3 Competent Cells
10.1.4 Reagents
10.1.5 Instruments
10.1.6 Services
10.2 ASEAN Protein Expression Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Industrial
10.2.3 Research
10.2.4 Therapeutic
10.3 ASEAN Protein Expression Market (2017-2032) by System Type
10.3.1 Market Overview
10.3.2 Mammalian Cell Expression System
10.3.3 Yeast Cell Expression System
10.3.4 Insect Cell Expression System
10.4 ASEAN Protein Expression Market (2017-2032) by End User
10.4.1 Market Overview
10.4.2 Academic Research
10.4.3 Contract Research Organizations
10.4.4 Pharmaceutical & Biotechnology Companies
11 Australia Protein Expression Market (2017-2032)
11.1 Australia Protein Expression Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Expression Vectors
11.1.3 Competent Cells
11.1.4 Reagents
11.1.5 Instruments
11.1.6 Services
11.2 Australia Protein Expression Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Industrial
11.2.3 Research
11.2.4 Therapeutic
11.3 Australia Protein Expression Market (2017-2032) by System Type
11.3.1 Market Overview
11.3.2 Mammalian Cell Expression System
11.3.3 Yeast Cell Expression System
11.3.4 Insect Cell Expression System
11.4 Australia Protein Expression Market (2017-2032) by End User
11.4.1 Market Overview
11.4.2 Academic Research
11.4.3 Contract Research Organizations
11.4.4 Pharmaceutical & Biotechnology Companies
12 Regulatory Framework
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share by Top 5 Companies
17.2 Merck KGaA
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Thermo Fisher Scientific Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 GenScript Biotech Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Agilent Technologies, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Takara Bio Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Bio-Rad Laboratories, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 QIAGEN
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Promega Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 GE Healthcare
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Bioneer Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
18 Asia Pacific Protein Expression Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The Asia Pacific protein expression market is expected to be driven by the rising demand for the global protein expression market, which is anticipated to grow at a CAGR of 5.40% during the forecast period of 2024-2032 and is likely to reach a market value of USD 4.9 billion by 2032.
The rising healthcare expenditures and growing prevalence of chronic diseases are fuelling the demand for the market.
One of the significant trends in the market is the increased investment in biologics manufacturing facilities which is likely to stimulate technological advancement and innovation in protein expression technologies. In November 2023 , an Indian-based CDMO Aragen Life Sciences announced the confirmation of USD 30 million for setting up a biologics manufacturing site in Bengaluru (India) to boost its bioproduction capabilities including the production of therapeutic proteins.
Based on the product, the market is segmented into expression vectors, competent cells, reagents, instruments, and services.
By system type, the market is divided into mammalian cell expression system, yeast cell expression system, and insect cell expression system.
End users of the market are academic research, contract research organizations, and pharmaceutical & biotechnology companies.
Major applications in the market include industrial, research, and therapeutic.
The market segmentation by countries includes China, Japan, India, ASEAN, and Australia, among others.
The key players in the market are Merck KGaA, Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Agilent Technologies, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., QIAGEN, Promega Corporation, GE Healthcare, and Bioneer Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER